This inventor holds 2 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Smithkline Beecham Laboratoires Pharmaceutiques. Active years: 2001-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,198 
1 out of 4 Years Active: 2001-2002
Title: Inventor Spotlight: Thierry Paul Gerard Calmels
Introduction
Thierry Paul Gerard Calmels is a distinguished inventor based in Pace, France. He holds two patents that illustrate his significant contributions in the fields of biotechnology and medical treatments. His work is pivotal in developing therapeutic solutions for complex medical conditions.
Latest Patents
One of Calmels' latest patents focuses on Kv potassium channel polypeptides and polynucleotides, specifically hKv4.3 polypeptides and polynucleotides. This patent encompasses methods for producing such polypeptides using recombinant techniques. Additionally, it details how these hKv4.3 polypeptides and polynucleotides can be utilized in designing protocols for treating cardiac arrhythmias and Alzheimer's disease, among other diagnostic assays for these conditions. Another significant patent involves Rhotekin polypeptides and polynucleotides, along with methods for their production by recombinant techniques, aimed at improving diagnostic assays.
Career Highlights
Throughout his career, Thierry Calmels has been associated with prominent companies such as SmithKline Beecham Laboratoires Pharmaceutiques and SmithKline Beecham Corporation. His experiences in these organizations allowed him to refine his skills and contribute to groundbreaking research in biotechnology.
Collaborations
Thierry Calmels has collaborated with notable coworkers, including Antoine Michel, Alain Bril, and Jean-Francois Simon Pierre Faivre. These partnerships have enhanced the innovation and effectiveness of his projects, underscoring the power of teamwork in scientific advancements.
Conclusion
Thierry Paul Gerard Calmels stands out as a key inventor in the realm of biotechnology. His patents and collaborations showcase his commitment to innovating solutions for serious health issues. His work continues to hold promise for advancements in the treatment of cardiac arrhythmias and Alzheimer's disease, paving the way for future research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile